Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. APTV
APTV logo

APTV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Aptiv PLC (APTV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
66.640
1 Day change
-0.60%
52 Week Range
88.930
Analysis Updated At
2026/03/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Aptiv PLC (APTV) is a good buy for a long-term beginner investor with $50,000-$100,000 available for investment. Despite short-term technical weakness and mixed financial performance, the upcoming Versigent spin-off, strong analyst sentiment, and compelling valuation make this an attractive opportunity for long-term growth.

Technical Analysis

The technical indicators are mixed. The MACD is positive and expanding, suggesting bullish momentum, but the RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 70.348, with support at 68.224 and resistance at 72.472. Short-term trends suggest potential downside (-1.6% next day, -7.38% next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • The upcoming Versigent spin-off on April 1, which analysts believe unlocks significant shareholder value. UBS suggests investors are effectively receiving Versigent for free at current prices.

  • Analysts have upgraded the stock with price targets ranging from $95 to $106, indicating strong upside potential.

  • The company is strategically optimizing its capital structure with a $1.371 billion tender offer ahead of the spin-off.

Neutral/Negative Catalysts

  • Weak Q4 2025 financial performance, with net income and EPS dropping significantly (-48.51% and -43.86% YoY, respectively).

  • Bearish moving averages and potential short-term downside in stock price.

  • Broader market weakness, with the S&P 500 down -1.79%.

Financial Performance

In Q4 2025, revenue increased by 5.01% YoY to $5.15 billion, but net income dropped by -48.51% YoY to $138 million. EPS declined by -43.86% YoY to $0.64, and gross margin fell to 17.99% (-5.27% YoY). While revenue growth is positive, profitability metrics have weakened significantly.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is highly positive. UBS upgraded the stock to Buy with a $97 price target, citing compelling upside due to the Versigent spin-off. Other firms like Wells Fargo, BofA, and Piper Sandler have price targets ranging from $95 to $106, with arguments for undervaluation and growth potential in the auto-tech and Physical AI sectors.

Wall Street analysts forecast APTV stock price to rise
13 Analyst Rating
Wall Street analysts forecast APTV stock price to rise
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 66.640
sliders
Low
84
Averages
100.8
High
110
Current: 66.640
sliders
Low
84
Averages
100.8
High
110
Wells Fargo
Colin Langan
Overweight
maintain
$95 -> $93
AI Analysis
2026-03-31
New
Reason
Wells Fargo
Colin Langan
Price Target
$95 -> $93
AI Analysis
2026-03-31
New
maintain
Overweight
Reason
Wells Fargo analyst Colin Langan lowered the firm's price target on Aptiv to $93 from $95 and keeps an Overweight rating on the shares. The firm notes Q1 is largely trending as expected and therefore Wells anticipates most suppliers to be in line. With that said, almost all drivers are trending worse for full year. Wells is more cautious given likely weaker China LVP and further Iran conflict downside risk. FX tailwinds have eased with a stronger USD.
RBC Capital
Outperform
to
Outperform
downgrade
$104 -> $81
2026-03-30
New
Reason
RBC Capital
Price Target
$104 -> $81
2026-03-30
New
downgrade
Outperform
to
Outperform
Reason
RBC Capital lowered the firm's price target on Aptiv to $81 from $104 but keeps an Outperform rating on the shares. The company's Versigent spinoff could unlock value for shareholders, though geopolitical headwinds could prevent multiples from re-rating immediately, the analyst tells investors in a research note. Following the spin, the software-oriented remain-co could also generate new investor interest, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for APTV
Unlock Now

People Also Watch